Skip to main content
. 2018 Oct 25;119(9):1044–1051. doi: 10.1038/s41416-018-0300-x

Fig. 2.

Fig. 2

Willingness of participants to use bleomycin in patients with pulmonary risk factors (a) and willingness to use bleomycin in those with pre-existing co-morbidities (b)